# A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors

> **NCT06730386** · PHASE1 · RECRUITING · sponsor: **Akeso** · enrollment: 100 (estimated)

## Conditions studied

- Solid Cancer

## Interventions

- **DRUG:** AK138D1

## Key facts

- **NCT ID:** NCT06730386
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-24
- **Primary completion:** 2028-02-26
- **Final completion:** 2028-08-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06730386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06730386, "A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06730386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*